Menu
Recruiting NCT06936202

Effects of Spirulina Supplementation on Mental Health in Healthy Adults

No phase Interventional Depression Mental Acuity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Spirulina capsules, Placebo.
Who it may be relevant to
Registry conditions: Depression, Mental Acuity. Basic parameters: 16 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Spirulina platensis is a form of cyanobacteria, a blue-green algae, and is a superfood most known for being rich in protein, vitamins and minerals, and healthful phytochemicals. Spirulina supports brain health through neuroprotection offered by its antioxidants, anti-inflammatory properties, and hormone regulation. The aim of this study is to supplement healthy adults from a campus community with 3g of spirulina, daily, for 8 weeks to improve mood and mental acuity in comparison to receiving a placebo.

Detailed description

Spirulina is nutrient-dense with vitamins and minerals which provide antioxidants and anti-inflammatory mechanisms to help reduce oxidative stress and ROS activity. Preclinical studies have indicated Spirulina can reduce inflammatory cytokines, such as IL-1β, and reverse stress responses and oxidative damage in BDNF, nuclear factor erythroid 2-related factor (NRF2), and ultimately the phosphorylation of protein-kinase B (AKT), which promotes cell growth. In addition to these benefits, fatty acids, gamma-linolenic acid (GLA) and glycolipids, support gut health and the immune system. In combination, all these nutrients help increase neuroprotection and brain health.

It is evident that Spirulina supports brain health through neuroprotection, antioxidants, anti-inflammatory properties, and hormone regulation. Research supports Spirulina reversing neurodegenerative diseases due to several of these beneficial properties. There have been many studies that utilize Spirulina to improve cognitive function in Alzheimer's Disease, Parkinson's Disease, ulcerative colitis, IBD, fibromyalgia and even in TBI and Ischemic stroke.

Although many of these diseases have depressive symptoms, few of these studies have evaluated the impact of Spirulina on mood. Furthermore, no studies have been conducted relating depression and the cyanobacteria. It is possible that Spirulina supplements can be used to reduce feelings of hopelessness and lack of energy, by providing additional vitamins, minerals, amino acids, and fatty acids, on a daily basis. This study aims to compare spirulina and its improvement on mood, in health college students, by daily supplementation of 3g of Spirulina over a span of 8 weeks.

Interventions

  • Other Spirulina capsules
    active intervention
  • Other Placebo
    no active ingredient

Primary outcome measures

  • POMS (profile of mood states questionnaire) [Time frame: conducted at baseline and at week 8 (study's end)]
  • Trail Making Test [Time frame: conducted at baseline and at week 8 (study's end)]

Eligibility criteria

Inclusion criteria

  • healthy adults
  • ages 18-65
  • no underlying chronic disease or acute conditions
  • no autoimmune conditions
  • do not consume alcohol in excess, smoke, use recreational drugs
  • does not follow restrictive diets
  • will be recruited from the ASU university campus.

Exclusion criteria

  • not have been clinically diagnosed with depression
  • not taking antidepressants, anxiety, or stress medications, or any other medications
  • drugs, or supplements that could influence mental capacities
  • not pregnant or breastfeeding
  • not a competitive athlete

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Prevention

Study locations

United States · 1 center
  • 850 PBC — Phoenix

Identifiers

NCT: NCT06936202 · STUDY00021993

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗